McCubrey, J.A.; Abrams, S.L.; Steelman, L.S.; Cocco, L.; Ratti, S.; Martelli, A.M.; Lombardi, P.; Gizak, A.; Duda, P.
APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells. Biomolecules 2022, 12, 276.
https://doi.org/10.3390/biom12020276
AMA Style
McCubrey JA, Abrams SL, Steelman LS, Cocco L, Ratti S, Martelli AM, Lombardi P, Gizak A, Duda P.
APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells. Biomolecules. 2022; 12(2):276.
https://doi.org/10.3390/biom12020276
Chicago/Turabian Style
McCubrey, James Andrew, Stephen L. Abrams, Linda S. Steelman, Lucio Cocco, Stefano Ratti, Alberto M. Martelli, Paolo Lombardi, Agnieszka Gizak, and Przemysław Duda.
2022. "APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells" Biomolecules 12, no. 2: 276.
https://doi.org/10.3390/biom12020276
APA Style
McCubrey, J. A., Abrams, S. L., Steelman, L. S., Cocco, L., Ratti, S., Martelli, A. M., Lombardi, P., Gizak, A., & Duda, P.
(2022). APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells. Biomolecules, 12(2), 276.
https://doi.org/10.3390/biom12020276